13F filer · CIK 1697748 ↗

ARK Invest

You are looking at Q1 2025. See the latest, Q2 2026 →

Reported value

$9.99B

−17% on the quarter before

Positions

196

22 new · 9 sold out

Top 10

48.5%

of the value

Est. gain

−$1.66B

on stocks held all quarter

Est. return

−15.2%

on those stocks since Q4 2024

Filed

May 7, 2025

On SEC EDGAR ↗

Positions as of Mar 31, 2025, from ARK Invest's 13F filing with the SEC. A 13F lists a manager's US-listed stocks and options at a quarter end and is filed up to 45 days later, so the fund may hold something else today. It leaves out short positions, cash and holdings outside the US.

Portfolio at a glance

  • New
  • Added
  • Cut
  • Same
  • Options

Each tile is a position, sized by its share, colored by what the fund did with it since Q4 2024. Striped tiles are options.

172 others26%
Tesla8.5%
Roku Inc6.1%
Palantir5.3%Roblox5.3%Coinbase5.3%Robinhood4.3%
Shopify Inc4.2%
Tempus AI3.6%
Crispr Therapeutics Ag3.5%
Twist Bioscience Corp2.5%
Meta2.4%
Ark 21shares Bitcoin ETF2.4%
Block2.2%Amazon2.0%
Archer Aviation Inc1.9%
Teradyne1.9%
Recursion Pharmaceuticals Inc1.8%
Pagerduty Inc1.7%
Beam Therapeutics Inc1.7%
Draftkings Inc1.6%
AMD1.5%
Iridium Communications Inc1.3%
Natera Inc1.3%
Pinterest Inc1.3%

Largest buys

Since Q4 2024, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.

  1. Tempus AI~$95.6MAdded · 1.6% → 3.6%+1,981,755 shares
  2. Deere & Co~$69.2MAdded · 0.3% → 1.1%+147,351 shares
  3. Iridium Communications Inc~$65.1MAdded · 0.6% → 1.3%+2,383,962 shares
  4. Gitlab Inc~$59.5MAdded · 0.5% → 1.1%+1,265,830 shares
  5. Crispr Therapeutics Ag~$40.6MAdded · 2.9% → 3.5%+1,192,336 shares
  6. Amazon~$30.1MAdded · 1.6% → 2.0%+158,431 shares
  7. Beam Therapeutics Inc~$27.6MAdded · 1.5% → 1.7%+1,412,060 shares
  8. Teradyne~$26.5MAdded · 2.0% → 1.9%+320,580 shares
  9. Twist Bioscience Corp~$25.4MAdded · 2.2% → 2.5%+645,730 shares
  10. Ibotta Inc~$22.3MAdded · 0.1% → 0.3%+528,147 shares

Largest sells

Since Q4 2024, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.

  1. Roku Inc~$143.0MCut · 6.6% → 6.1%−2,029,908 shares
  2. Palantir~$127.3MCut · 4.9% → 5.3%−1,508,264 shares
  3. UiPath~$116.2MCut · 2.1% → 0.9%−11,283,479 shares
  4. Robinhood~$110.6MCut · 4.0% → 4.3%−2,658,513 shares
  5. Sofi Technologies Inc~$85.7MCut · 1.2% → 0.2%−7,366,793 shares
  6. Roblox~$62.4MCut · 4.9% → 5.3%−1,070,573 shares
  7. Block~$46.1MCut · 3.5% → 2.2%−848,409 shares
  8. Meta~$27.6MCut · 2.3% → 2.4%−47,925 shares
  9. Draftkings Inc~$23.4MCut · 1.7% → 1.6%−704,035 shares
  10. Rocket Lab Usa Inc~$19.1MCut · 0.7% → 0.4%−1,068,228 shares

Holdings

As of Mar 31, 2025. Changes are in shares against Dec 31, 2024, so a price move alone never reads as a buy or a sale.

Positions, sorted by share of the portfolio
HoldingValue
TeslaCommon Stock · shares −0.9% · price −35.8%8.5%$844.5M−$471.5M
Roku IncCommon Stock · shares −19% · price −5.2%6.1%$608.7M−$33.7M
PalantirCommon Stock · shares −19% · price +11.6%5.3%$530.5M+$55.1M
RobloxCommon Stock · shares −11% · price +0.7%5.3%$528.8M+$3.9M
CoinbaseCommon Stock · shares +1.1% · price −30.6%5.3%$528.6M−$230.8M
RobinhoodCommon Stock · shares −21% · price +11.7%4.3%$426.5M+$44.7M
Shopify IncCommon Stock · shares −1.3% · price −10.2%4.2%$424.3M−$48.2M
Tempus AICommon Stock · shares +36% · price +42.9%3.6%$361.9M+$79.9M
Crispr Therapeutics AgCommon Stock · shares +13% · price −13.5%3.5%$345.9M−$47.8M
Twist Bioscience CorpCommon Stock · shares +12% · price −15.5%2.5%$245.0M−$40.3M
MetaCommon Stock · shares −10% · price −1.6%2.4%$240.0M−$3.8M
Ark 21shares Bitcoin ETFETP · shares −7.4% · price −11.9%2.4%$235.9M−$31.8M
BlockCommon Stock · shares −17% · price −36.1%2.2%$221.6M−$125.1M
AmazonCommon Stock · shares +18% · price −13.3%2.0%$200.4M−$26.1M
Archer Aviation IncCommon Stock · shares −8.7% · price −27.1%1.9%$194.2M−$72.1M
TeradyneCommon Stock · shares +17% · price −34.4%1.9%$185.3M−$83.3M
Recursion Pharmaceuticals IncCommon Stock · shares +7.6% · price −21.7%1.8%$184.2M−$47.5M
Pagerduty IncCommon Stock · shares +1.9% · price +0.1%1.7%$167.6M+$89,964
Beam Therapeutics IncCommon Stock · shares +20% · price −21.2%1.7%$165.6M−$37.2M
Draftkings IncCommon Stock · shares −13% · price −10.7%1.6%$160.4M−$19.3M
AMDCommon Stock · shares +18% · price −14.9%1.5%$146.1M−$21.8M
Iridium Communications IncCommon Stock · shares +95% · price −5.9%1.3%$133.6M−$4.3M
Natera IncCommon Stock · shares +6.2% · price −10.7%1.3%$133.4M−$15.0M
Pinterest IncCommon Stock · shares −4.3% · price +6.9%1.3%$130.2M+$8.4M
Veracyte IncCommon Stock · shares −6.3% · price −25.1%1.2%$116.8M−$39.2M
Total · 196 positions100%$9.99B−$1.66B
The filing on SEC EDGAR ↗

Price is a stock's reported value over its shares at the quarter end. The estimated gain is the shares held at both quarter ends times the change in that price: shares bought or sold during the quarter add nothing, options are left out, and a stock split is read into the earlier share count and price.

What made money

From Q4 2024 to Q1 2025: 173 stocks held throughout, down $1.66B (−15.2%).

  1. Tempus AI+$79.9M+43%
  2. Palantir+$55.1M+12%
  3. Robinhood+$44.7M+12%
  4. Guardant Health Inc+$17.0M+39%
  5. Kratos Defense+$12.2M+13%
  6. The Trade Desk−$79.8M−53%
  7. Teradyne−$83.3M−34%
  8. Block−$125.1M−36%
  9. Coinbase−$230.8M−31%
  10. Tesla−$471.5M−36%

Estimated as in the holdings table: shares held at both quarter ends times the change in price; options left out.

Reported value by quarter

The total value of each quarter's 13F at that quarter end. It moves with prices as well as with buying and selling. Pick a quarter to see what the fund held then.

$60.00B$30.00B$0
Q4 2016Q2 2026
Every quarter's filing
Each quarter's 13F filing, newest first
QuarterReported valueFiling
Q2 2026$15.40B+20%SEC ↗
Q1 2026$12.86B−15%SEC ↗
Q4 2025$15.07B−10%SEC ↗
Q3 2025$16.80B+23%SEC ↗
Q2 2025$13.64B+37%SEC ↗
Q1 2025$9.99B−17%SEC ↗
Q4 2024$12.01B+10%SEC ↗
Q3 2024$10.93B−3%SEC ↗
Q2 2024$11.27B−22%SEC ↗
Q1 2024$14.44B−14%SEC ↗
Q4 2023$16.89B+29%SEC ↗
Q3 2023$13.07B−13%SEC ↗
Q2 2023$15.10B+4%SEC ↗
Q1 2023$14.55B+26%SEC ↗
Q4 2022$11.54B−20%SEC ↗
Q3 2022$14.35B−15%SEC ↗
Q2 2022$16.91B−29%SEC ↗
Q1 2022$23.96B−28%SEC ↗
Q4 2021$33.08B−21%SEC ↗
Q3 2021$41.64B−23%SEC ↗
Q2 2021$53.74B+7%SEC ↗
Q1 2021$50.34B+34%SEC ↗
Q4 2020$37.59B+123%SEC ↗
Q3 2020$16.86B+81%SEC ↗
Q2 2020$9.30B+132%SEC ↗
Q1 2020$4.01B+1%SEC ↗
Q4 2019$3.96B−13%SEC ↗
Q3 2019$4.58B+15%SEC ↗
Q2 2019$3.97B+13%SEC ↗
Q1 2019$3.50B+42%SEC ↗
Q4 2018$2.46B−26%SEC ↗
Q3 2018$3.31B+21%SEC ↗
Q2 2018$2.73B+36%SEC ↗
Q1 2018$2.01B+60%SEC ↗
Q4 2017$1.26B+53%SEC ↗
Q3 2017$819.3M+60%SEC ↗
Q2 2017$513.6M+48%SEC ↗
Q1 2017$346.9M+26%SEC ↗
Q4 2016$274.9MSEC ↗

Get the newsletter

The day's AI and market news, in your inbox every weekday.